Author: Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.
Finance, Software

Bitcoin News: Bitcoin-Backed Money To Get A Big Boost From Philippine Government Bill

A member of the House of Representatives of the Philippines has introduced a bill that would seek to create a government-backed “e-peso” that would serve as an official medium of exchange for domestic online payments. Introduced as part of the E-Peso Act of 2014, the payments tool would be considered legal tender for debt, taxes and goods and services, according to a report by The … Continue reading Bitcoin News: Bitcoin-Backed Money To Get A Big Boost From Philippine Government Bill

Richard Atkins
Finance, Mobile

(NASDAQ AAPL) Apple Opening Up Another Store in Turkey

Apple Inc (NASDAQ AAPL) is expanding retail presence in Turkey. After a huge retail store launch in Instabul in early 2014, The iPhone maker is set to launch it’s second store inside Instanbul’s Akasya Shopping Center. The first Apple store in Instabul was located at the upscale Zorlu center. It is located in a subterranean spot underneath a mall plaza. However, the second store will … Continue reading (NASDAQ AAPL) Apple Opening Up Another Store in Turkey

Richard Atkins
Finance, Internet

Active Stock: Google (NASDAQ GOOG) Q3 Earnings Preview

Google Inc (NASDAQ GOOG) is scheduled to release and discuss its third-quarter financial result on Thursday, October 16 at 1:30 P.M. Pacific Time. Analysts at Bernstein Research believed that investors are still primarily focused on the company’s revenue growth sustainability, the trajectory of its operating expenses, margin and capex. According to Bernstein Research analysts Carlos Kijner and Peter Paskhaver, their third-quarter revenue and EBITDA estimates … Continue reading Active Stock: Google (NASDAQ GOOG) Q3 Earnings Preview

Richard Atkins
Finance, Internet

Stock in News: Facebook (NASDAQ FB) Popularity Decreases Among Teens

Facebook is not as much fun for teens as Instagram and other social networking sites are, reveals a survey. Facebook Inc (NASDAQ FB) is losing popularity among teens as more and more youngsters prefer Instagram and Twitter Inc (NYSE TWTR) to fulfill their social media needs, says a report from Piper Jaffray. There is no mention of Vine or Snapchat in the survey, which is … Continue reading Stock in News: Facebook (NASDAQ FB) Popularity Decreases Among Teens

Richard Atkins
SAP Cloud Storage
Analysis, Software

Contracting in IT: Tips to build up a client base to get started

Starting a new business is always a precarious time, leaving the security of paid employment and being solely responsible for generating an income for yourself. One thing a freelancer or contractor needs to become a success is a good client base that will offer regular and continuous work. Just how do you go about building a client base? The first place to look for new … Continue reading Contracting in IT: Tips to build up a client base to get started

Richard Atkins
Biotechnology Stockmarket Biotech
BioTech, Finance

Sunesis Pharmaceuticals Stock Down : Biotech Trial Failure

Shares of Sunesis Pharmaceuticals, Inc (SNSS) plunged significantly after the company announced that its phase III trial, VALOR, failed to meet its primary endpoint. The randomized, double-blind, placebo-controlled trial (n=711) evaluated the efficacy of Qinprezo (vosaroxin) and cytarabine in patients suffering from first relapsed or refractory acute myeloid leukemia (AML). The trial failed to reach its primary endpoint of a statistically significant improvement in overall … Continue reading Sunesis Pharmaceuticals Stock Down : Biotech Trial Failure

Richard Atkins